BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Framework Agreement has been established for the supply of pralidoxime chloride for injection, to place call-offorders as and when required during the life of the Framework Agreement.
The duration of the Framework Agreement is 2 years with an option to extend for up to an additional 2 years.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Baxter Healthcare Ltd | 00461365 | ~£0 estimated from lot values | LOBBYIST WA Communications Ltd (3 quarters) |
Government spending data: This supplier has received £286,227,638 in 8,040 payments (over £25k) from The Christie NHS Foundation Trust, Department of Health and Social Care, NHS Supply Chain (DHSC-funded), Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust and 11 more public bodies (2010-04-01 to 2026-03-31). View full payment history →